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Abstract
Background: Increasing cell membrane permeability to water and cryoprotectants is critical for the successful
cryopreservation of cells with large volumes. Artificial expression of water-selective aquaporins or aquaglyceroporins
(GLPs), such as mammalian aquaporin-3 (AQP3), enhances cell permeability to water and cryoprotectants, but it is
known that AQP3-mediated water and solute permeation is limited and pH dependent. To exploit further the
possibilities of using aquaporins in cryobiology, we investigated the functional properties of zebrafish (Danio rerio) GLPs.
Results: Water, glycerol, propylene glycol and ethylene glycol permeability of zebrafish Aqp3a, -3b, -7, -9a, -9b,
-10a and -10b, and human AQP3, was examined. Expression in Xenopus laevis oocytes indicated that the
permeability of DrAqp3a and -3b to ethylene glycol was higher than for glycerol or propylene glycol under
isotonic conditions, unlike other zebrafish GLPs and human AQP3, which were more permeable to glycerol. In
addition, dose-response experiments and radiolabeled ethylene glycol uptake assays suggested that oocytes
expressing DrAqp3b were permeated by this cryoprotectant more efficiently than those expressing AQP3. Water
and ethylene glycol transport through DrAqp3a and -3b were, however, highest at pH 8.5 and completely
abolished at pH 6.0. Point mutations in the DrAqp3b amino acid sequence rendered two constructs, DrAqp3b-
T85A showing higher water and ethylene glycol permeability at neutral and alkaline pH, and DrAqp3b-H53A/G54H/
T85A, no longer inhibited at acidic pH but less permeable than the wild type. Finally, calculation of permeability
coefficients for ethylene glycol under concentration gradients confirmed that the two DrAqp3b mutants were
more permeable than wild-type DrAqp3b and/or AQP3 at neutral pH, resulting in a 2.6- to 4-fold increase in the
oocyte intracellular concentration of ethylene glycol.
Conclusion: By single or triple point mutations in the DrAqp3b amino acid sequence, we constructed one mutant
with enhanced ethylene glycol permeability and another with reduced pH sensitivity. The DrAqp3b and the two
mutant constructs may be useful for application in cryobiology.
Background
Over the last decades, advances in understanding basic
phenomena in cryobiology has led the development of
effective methods for the preservation of a very wide
range of cells [1]. However, the cryopreservation of cells
with large volumes and multicellular systems and tis-
sues, such as vertebrate oocytes and embryos, still
remains a challenge in some cases [2-4]. Vertebrate
oocytes show low surface area to volume ratio and low
permeability to water and cryoprotectants, and as a con-
sequence they are highly susceptible to formation of
intracellular ice, cryoprotectant-toxicity, and osmotic
stress. In addition, oocyte cryosurvival may change dur-
ing development or as a result of different genotypes
[4,5].
One of the major obstacles with freezing of a cell is
that intracellular water content crystallizes, leading to
mechanical and physical damage [6,7]. To limit the rate
of ice crystals formation, the first step is to permeate
cells with cryoprotectant agents, such as glycerol, propy-
lene glycol, dimethyl sulfoxide or ethylene glycol, which
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should reach high intracellular concentrations, thus gen-
erating the driving force for the efflux of water by osmo-
sis and of solutes by diffusion [6,7]. This can be
achieved either by a slow cooling rates with low concen-
tration of cryoprotectants, or fast cooling after incuba-
tion in highly concentrated cryoprotectant solutions
(vitrification) [8,9]. An ideal cryoprotectant should thus
exhibit low toxicity and rapidly permeate the cell, so
that osmotic volume changes, that are a recognized
form of cellular stress, are minimized [10-12]. Ethylene
glycol shows the best efficiency/toxicity ratio on mam-
malian oocytes and embryos and is thus the most com-
mon selected cryoprotectant for slow-cooling or
vitrification protocols [13-18]. However, the permeability
of vertebrate oocytes and embryos to ethylene glycol is
limited [19-24] and may change during development
and differentiation [3,4], resulting possibly in intracellu-
lar damage after cryopreservation [4,16,25].
It is now well established that biological membranes
allow water to pass by simple diffusion through the lipid
bilayer, or when rapid water permeability is required (in
case of reabsorption, secretion or osmotic stress),
through specialized membrane channels known as aqua-
porins. Aquaporins (AQPs) are integral membrane pro-
teins present in all living organisms from bacteria to
mammals [26]. These proteins consist of six transmem-
brane helices connected by five loops, two of which bear
the highly conserved asparagine-proline-alanine (NPA)
motifs involved in the formation of the water pore [26].
To date, 13 aquaporins have been identified in mam-
mals (AQP0-12) and while most of them are water-
selective, functional studies have identified a subgroup
of channels (AQP3, -7, -9 and -10) that can transport
also glycerol and urea, and are termed aquaglyceropor-
ins (GLPs) [26,27]. Some GLPs are also permeated by
metalloids and a wide variety of noncharged solutes (e.
g., carbamides, polyols, purines, pyrimidines), including
cryoprotectants such as propylene glycol, ethylene gly-
col, acetamide and possibly dimethyl sulfoxide [28-32].
The discovery of aquaporins made it possible to use
them for enhancing water and cryoprotectant permeabil-
ity of cells [33-35]. In the baker’s yeast (Saccharomyces
cerevisiae), freeze tolerance during rapid freezing condi-
tions positively correlates with high levels of expression
of the water-selective aquaporins Aqy1 and Aqy2 [33,36].
This positive effect has been explained by the rapid water
efflux, especially at freezing temperatures, as a conse-
quence of high levels of aquaporins in the plasma mem-
brane of yeast cells, resulting in the reduction of
intracellular ice crystal formation and cell damage. Simi-
larly, heterologous expression of wild-type (WT) mam-
malian aquaporin-3 (AQP3) in vertebrate oocytes and
embryos enhances both the efflux of water and influx of
cryoprotectants into the cells [31,34,35,37-41]. In the
case of mouse oocytes, this method ameliorates oocyte
tolerance to freezing and survival after thawing [35].
The increased permeability mediated by the artificial
expression of AQP3 may be however insufficient for
cryosurvival of cells or multicellular systems with large
volumes, such as oocytes and embryos from lower verte-
brates [39]. This may be related to a decreased transla-
tion efficiency of AQP3 when expressed in an
heterologous system and/or a limited water and solute
permeability of AQP3 [39,42,43]. In addition, AQP3 is
pH-dependant [44], and therefore, an effect of pH on
AQP3-mediated water and cryoprotectant transport is
likely to occur. This additional obstacle should be con-
sidered when using AQP3 in cryobiology as the intracel-
lular pH is altered during volumetric changes in cells
exposed to hypertonic or hypotonic environments
[45-47]. Furthermore, the intracellular pH can be
affected by the presence of cryoprotectants within the
cell as some of them are dipolar aprotic or protic sol-
vents and act as hydrogen bond acceptors or proton
donors, and affect the acid-base equilibrium in mixed
solvent systems [46]. Therefore, exploiting further the
possibilities of using aquaporins in cryobiology, it would
be useful to develop aquaporins with enhanced perme-
ability or pH insensitivity, by investigating GLPs of non-
mammalian origin that may be more permeable to
water and cryoprotectants than mammalian AQP3.
Recently, we have characterized the genomic reper-
toire of zebrafish (Danio rerio) aquaporins which con-
tains seven GLP isoforms: DrAqp3a and -3b, DrAqp7,
DrAqp9a and -9b, and DrAqp10a and -10b [48]. Func-
tional expression in Xenopus laevis oocytes demon-
strated that all the zebrafish GLPs transport water,
glycerol and urea in a similar manner as the mammalian
orthologs [48], and therefore these channel proteins are
of potential interest for cryobiology. In the present
study, we have investigated both the pH sensitivity and
cryoprotectant permeability of the zebrafish GLPs by
using the X. laevis oocyte expression system. Interest-
ingly, we found that both DrAqp3a and -3b isoforms are
much more permeable to ethylene glycol than to gly-
cerol or propylene glycol at neutral or alkaline pH,
while all other zebrafish GLPs, as well as human AQP3,
are more permeable to glycerol. Since ethylene glycol is
a suitable cryoprotectant, we further engineered two
DrAqp3 mutants that were insensitive to changes in pH
or exhibit enhanced ethylene glycol permeability.
Results
Effect of pH on water and cryoprotectant permeability of
zebrafish GLPs and human AQP3
The effect of external pH on water permeability of
X. laevis oocytes injected with capped RNA (cRNA)
encoding DrAqp3a -3b, -7, -9a, -9b, -10a, or -10b was
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determined by measuring the rate of swelling in hypo-
tonic modified Barth’s medium (MBS) (Figure 1). For
comparison, oocytes were injected with DrAqp1a or
human AQP3 (HsAQP3). The pH of the incubation
medium affected the osmotic water permeability (Pf) of
oocytes expressing HsAQP3, DrAqp3a, -3b, -7, and
-10b, whereas the Pf of oocytes injected with DrAqp1a,
-9a, -9b, and -10a did not changed significantly within
the range of pH tested. However, the effect of pH on
oocyte Pf relied on the specific expressed aquaporin.
Thus, the Pf of oocytes expressing DrAqp7 was inhibited
by approximately 50% at pH 6, whereas the DrAqp10b
oocytes, exhibiting very low water permeability at pH 6
and 7.5 (approximately 1.5-fold increase in both cases
with respect the control oocytes), showed an enhanced
Pf at pH.8.5 (2.5-fold increase). For oocytes expressing
HsAQP3 or zebrafish AQP3 isoforms, the Pf was inhib-
ited at acidic pH but in a different manner. The Pf of
HsAQP3 oocytes was only partially inhibited (by
approximately 55%) at pH 6, whereas it remained simi-
lar at neutral and basic pH, as it has been described pre-
viously [44]. In contrast, the Pf of DrAqp3a and -3b
oocytes was completely abolished at pH 6, and was
higher at basic than at neutral pH. Thus, in DrAqp3a
oocytes the Pf increased by 5- and 10-fold with respect
the control oocytes at pH 7.5 and 8.5, respectively,
whereas the Pf of DrAqp3b oocytes increased by 2.5-
and 11-fold at pH 7.5 and 8.5, respectively. It thus
appears that human AQP3 and the zebrafish orthologs
exhibit different sensitivity to pH.
The permeability of X. laevis oocytes expressing
HsAQP3 or zebrafish GLPs to the cryoprotectants gly-
cerol, propylene glycol and ethylene glycol (PGly, PPG
and PEG, respectively) at different pH was determined
volumetrically. In these experiments, control and aqua-
porin-expressing oocytes were exposed to isotonic solu-
tions containing 160 mM of the respective solutes and
changes in oocyte volume were recorded during 1 min.
In general, the solute permeability (PS) of control
oocytes and of oocytes expressing the different GLPs
was affected by changes in pH (Table 1). Calculation of
the oocyte PS as fold increase with respect that of the
controls revealed that the pH changed the PS in a man-
ner similar to the Pf, except for oocytes expressing
HsAQP3 which PEG remained unchanged regardless of
the pH of the medium (Table 1). Oocytes expressing
DrAqp7, -9a, -9b, -10a and -10b, or HsAQP3, were sig-
nificantly (p < 0.05) more permeable to glycerol than
propylene glycol or ethylene glycol at pH 7.5 (Table 1).
In contrast, DrAqp3a or -3b oocytes exhibited signifi-
cantly (p < 0.05) higher permeability to ethylene glycol
than to the other cryoprotectants at pH 7.5 or 8.5. At
pH 8.5, the PEG of DrAqp3b oocytes was greatly
enhanced resulting in bursting of the oocytes. To
Figure 1 Effect of pH on zebrafish GLPs and Aqp1a and human
AQP3 expressed in X. laevis oocytes. Oocytes were injected with
1 ng (DrAqp3b, -7, -9a, -9b, -10a, -1a or HsAQP3) or 10 ng (DrAqp3a
and -10b) cRNA, or with 50 nl of water (controls). The osmotic
water permeability (Pf) was measured in 10 times diluted MBS after
15 min of exposure to isotonic MBS at pH 6, 7.5 or 8.5. The swelling
experiments were also performed at the corresponding pH. Data
are the means ± SEM of three experiments (n = 10-12 oocytes for
each aquaporin). Bars with different superscript in each panel
indicate significant differences (ANOVA, p < 0.05) in Pf between
aquaporin-injected oocytes. The asterisks denote significant
differences with respect the control oocytes at a given pH
(Student’s t test, p < 0.05).
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prevent this, oocytes were exposed to 100 mM ethylene
glycol instead of 160 mM, confirming the stimulatory
effect of increasing pH on the PEG of oocytes expressing
DrAqp3b (data not shown).
In order to assure that the effect of pH on the Pf or
PEG of DrAqp3b-expressing oocytes was not affected by
the dilution of the ion concentrations in the MBS solu-
tion, oocytes were equilibrated in isotonic MBS contain-
ing sucrose, and a lower concentration of NaCl, prior to
the swelling assays (see Methods). These experiments
confirmed that the Pf or PEG at different pH of oocytes
expressing DrAqp3b was identical regardless of the ion
concentrations of the bathing solutions (Additional file
1), and therefore subsequent Pf assays were carried out
in diluted MBS.
To further determine whether the ethylene glycol per-
meability of oocytes expressing DrAqp3b was higher
than that of oocytes expressing HsAQP3, oocytes from
the same batch were injected with increasing amounts
of cRNA (1 to 40 ng) encoding HsAQP3 or DrAqp3b
(Figure 2). Determination of the oocyte PEG for each
cRNA dose at pH 7.5 showed that the PEG of both
HsAQP3- and DrAqp3b-injected oocytes reached a pla-
teau with 20 ng cRNA, but the PEG of DrAqp3b oocytes
was significantly (p < 0.01) higher than that of the
HsAQP3 oocytes at all tested cRNA doses (Figure 2A).
Since the oocyte expression system was apparently satu-
rated with the same cRNA dose in HsAQP3- and
DrAqp3b-expressing oocytes, the differences in PEG
were likely not derived from differences in translation
efficiency. To confirm that DrAqp3b-expressing oocytes
permeated ethylene glycol more efficiently than those
expressing HsAQP3, oocytes injected with 20 ng
DrAqp3b or HsAQP3 cRNA were exposed to radiola-
beled ethylene glycol. These experiments showed that
the uptake of isotope-labeled ethylene glycol by
DrAqp3b oocytes was approximately 70% higher than in
HsAQP3 oocytes (Figure 2B). Altogether, these results
suggested that DrAqp3b was more permeable to ethy-
lene glycol than to propylene glycol or glycerol, and that
DrAqp3b oocytes permeated ethylene glycol more effi-
ciently than those expressing HsAQP3.
Development of DrAqp3b mutants pH insensitive or with
enhanced water and ethylene glycol permeability
The finding that both zebrafish Aqp3 isoforms were
highly permeable to ethylene glycol prompted us to
design Aqp3 mutant constructs that would be pH insen-
sitive or show enhanced ethylene glycol permeability.
The design of the mutants was based on the DrAqp3b
deduced amino acid sequence (Figure 3 andTable 2)
since the corresponding cRNA was expressed apparently
more efficiently in X. laevis oocytes than that of
DrAqp3a. To characterize the DrAqp3b-WT and
mutants, their cRNAs were expressed in oocytes and the
Pf monitored at different pH (Figure 4A andAdditional
file 2).
To design DrAqp3b constructs encoding aquaporins
potentially pH insensitive, we targeted conserved resi-
dues that have been suggested to contribute to pH
Table 1 Cryoprotectant permeability (PS) of X. laevis oocytes expressing human AQP3 or zebrafish GLPs in isotonic
solutions at different pH containing 160 mM of solutes
PGly (x 10
-3 cm/min) PPG (x 10
-3 cm/min) PEG (x 10
-3 cm/min)
pH 6.0 pH 7.5 pH 8.5 pH 6.0 pH 7.5 pH 8.5 pH 6.0 pH 7.5 pH 8.5
HsAQP3 9.95 ± 1.17a
(1.64 ± 0.29)
35.22 ± 3.48c
(2.07 ± 0.32)
49.62 ± 5.96e
(3.13 ± 0.38)
10.05 ± 1.64a
(2.47 ± 0.29)
28.93 ± 3.62c
(3.13 ± 0.34)
38.14 ± 2.87cd
(5.23 ± 0.56)
18.34 ± 2.32b
(1.97 ± 0.31)
32.38 ± 2.87c
(4.30 ± 0.40)
36.53 ± 3.28c
(4.89 ± 0.62)
DrAqp3a 2.21 ± 0.40a
(1.45 ± 0.20)
4.64 ± 0.97b
(2.10 ± 0.30)
32.64 ± 4.53d
(3.33 ± 0.48)
5.73 ± 0.91b
(2.41 ± 0.21
16.09 ± 1.86c
(2.64 ± 0.28)
71.08 ± 6.85e
(5.41 ± 0.46)
3.76 ± 0.69ab
(1.83 ± 0.29)
20.63 ± 3.18c
(3.70 ± 0.66)
90.04 ± 6.02f
(3.77 ± 0.39)
DrAqp3b1 1.71 ± 0.43a
(1.11 ± 0.25)
12.81 ± 1.24b
(1.47 ± 0.31)
57.37 ± 3.03d
(2.93 ± 0.63)
1.92 ± 0.42a
(1.54 ± 0.33)
28.27 ± 2.51c
(3.77 ± 0.37)
70.08 ± 4.48e
(7.84 ± 0.98)
1.46 ± 0.29a
(1.15 ± 0.71)
79.22 ± 5.70e
(4.50 ± 0.50)
_
DrAqp7 nd 97.99 ± 7.16c
(3.85 ± 0.55)
nd nd 40.76 ± 3.37a
(3.34 ± 0.35)
nd Nd 50.55 ± 2.81b
(4.53 ± 0.57)
nd
DrAqp9a nd 27.58 ± 1.85a
(1.76 ± 0.16)
nd nd 29.40 ± 3.19a
(5.06 ± 0.37)
nd Nd 61.62 ± 4.45b
(7.75 ± 0.60)
nd
DrAqp9b nd 52.48 ± 3.54b
(1.92 ± 0.24)
nd nd 31.27 ± 4.39a
(3.94 ± 0.38)
nd Nd 56.03 ± 4.30b
(9.24 ± 0.70)
nd
DrAqp10a nd 31.05 ± 3.01b
(1.60 ± 0.23)
nd nd 13.02 ± 1.45a
(4.45 ± 0.41)
nd Nd 19.14 ± 1.17a
(6.99 ± 0.61)
nd
DrAqp10b 1.15 ± 0.16a
(1.29 ± 0.21)
2.29 ± 0.32b
(1.71 ± 0.26)
17.48 ± 2.25ef
(2.84 ± 0.52)
2.45 ± 0.50bc
(2.04 ± 0.30)
3.66 ± 0.51c
(2.59 ± 0.30)
13.21 ± 1.35e
(4.59 ± 0.56)
3.30 ± 0.99bc
(1.93 ± 0.30)
6.70 ± 0.82d
(3.67 ± 0.74)
18.58 ± 1.26f
(3.77 ± 0.41)
Data are the means ± SEM (n = 10-12 oocytes per treatment) of 3-4 experiments performed on different batches of oocytes. Due to natural variations in oocyte
permeability between batches of oocytes, the PS of water-injected oocytes (controls) is shown in parenthesis for each aquaporin. Oocytes were injected with 1
ng (DrAqp3b, -7, -9a, -9b, -10a, -1a, or HsAQP3) or 10 ng (DrAqp3a and -10b) cRNA, or with 50 nl of water. Data from the same row with different superscript are
statistically significant (ANOVA, p < 0.05). nd, not determined.
1 No data available for PEG at pH 8.5 because DrAqp3b-expressing oocytes burst in 160 mM ethylene glycol.
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sensitivity in vertebrate and plant aquaporins, such as
His, Arg, Glu and Tyr [49-53] (Table 2 and Figure 3).
Within the external loop A, fish and human AQP3 con-
tain a His residue (His53 in DrAqp3b) that is conserved
in killifish (Fundulus heteroclitus) Aqp0a (His39) (Figure
3), which is, as AQP3, less permeable at acidic pH [51].
However, bovine (Bos taurus) AQP0, where the His in
loop A is shifted one position (His40) as compared to
FhAqp0a (Figure 3), is more permeable at acidic pH
[50]. Expression of DrAqp3b-H53A (Figure 4A) or
-G54H (Additional file 2) in oocytes led to a global
decrease in water permeability with respect DrAqp3b-
WT oocytes and did not affect pH sensitivity. By moving
the His from position 53 to 54 (DrAqp3b-H53A/G54H),
oocyte permeability at pH 6 was increased by 97% (p <
0.05) with respect to DrAqp3b-WT oocytes. However,
the permeability at pH 7.5 and 8.5 of oocytes expressing
this mutant was reduced when compared with
DrAqp3b-WT oocytes (Figure 4A).
In the external loop C, the His154 of DrAqp3b is con-
served in FhAqp3a and HsAQP3 (Figure 3). This residue
in HsAQP3 has been proposed to participate in the pH
regulation of water permeability [49]. In DrAqp3b,
His154 was necessary for water permeability, since the Pf
at pH 6 and 7.5 of oocytes expressing DrAqp3b-H154A,
-G54H/H154A, -H53A/H154A or -H53A/G54A/H154A,
was strongly diminished with respect to that of the
DrAqp3-WT oocytes, although it was slightly less inhib-
ited at pH 8.5 (Additional file 2).
Since Tyr residues have been reported to be implied
in the pH sensitivity of HsAQP3 [49], and Arg residues
may create electrostatic barriers that regulate aquaporin
permeability [52], we also investigated the effect of
mutations in these residues. The Tyr182 in the internal
loop D of DrAqp3b is conserved in both fish and
human AQP3 but not in other zebrafish GLPs and
DrAqp1a (Figure 3). In addition, several Arg and Glu
residues in the internal loop B (Arg95, Glu96 and Arg99
in DrAqp3b) are highly conserved in vertebrate AQP3,
of which Arg95 is retained in DrAqp7 and -10b that
show decreased water permeability at pH 6 (Figure 1).
However, all the mutations performed at these sites
(DrAqp3b-R95A, -E96A, -R99A, and -Y182A) did not
affect significantly the Pf at any pH (Additional file 2),
suggesting that these residues are not essential for water
permeability or pH sensitivity in DrAqp3b.
The NPA motifs, together with the aromatic residue/
arginine (ar/R) constriction region (Figure 3), are
believed to be involved in proton exclusion and channel
selectivity of aquaporins [54,55]. Since DrAqp3b exhibits
a particular feature within the first NPA box, apparently
conserved in the Aqp3b of other teleosts [48], where the
Ala residue is replaced by a Thr (Figure 3), we investi-
gated whether the Thr85 of DrAqp3b can affect its per-
meability. The first NPT motif of DrAqp3b was mutated
into NPA (DrAqp3b-T85A; Table 2) and expressed in
oocytes. Two other mutants were produced bearing two
NPT motifs (DrAqp3b-A217T) or NPA-NPT motifs
(DrAqp3b-T85A/A217T). The oocytes expressing
DrAqp3b-T85A showed a significant (p < 0.05) 2.4- and
1.5-fold increase in Pf with respect oocytes expressing
Figure 2 PEG and ethylene glycol uptake of X. laevis oocytes
expressing HsAQP3 or DrAqp3b. (A) PEG of oocytes expressing
different amounts of cRNA (1-40 ng) encoding HsAQP3 or DrAqp3b.
Control oocytes were injected with 50 nl of water. The PEG was
measured by swelling measurements during 20 sec in isotonic MBS
containing 60 mM of ethylene glycol at pH 7.5. Values are the mean
± SEM of three experiments (n = 8-10 oocytes for each aquaporin).
Data with an asterisk at the same cRNA dose are significantly
different (Student’s t test, p < 0.01). (B) Uptake of radiolabeled
ethylene glycol of oocytes injected with 50 nl of water or 5 ng of
HsAQP3 or DrAqp3b cRNA. Oocytes were exposed to isotonic MBS
containing 1 mM cold ethylene glycol and 5 μM radiolabelled [1,2-
3H]ethylene glycol for 1 min. Values (mean ± SEM; n = 8-10
oocytes) with different superscript are significantly (ANOVA, p <
0.01).
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Figure 3 Amino acid sequence alignment of zebrafish GLPs, Aqp1a and Aqp0a with mammalian and teleost orthologs. Amino acid
sequence alignment of representative GLPs and water-selective aquaporins of teleosts and mammals: Danio rerio Aqp0a (DrAqp0a; FJ666326),
-0b (FJ655389), -3a (EU341833), -3b (EU341832), -7 (FJ655385), -9a (FJ655387), -9b (EU341835), -10a (FJ655388), -10b (EU341836), and -1a
(AY626937), Fundulus heteroclitus Aqp0a (FhAqp0; AF191906) and -3a (ACI49539), Homo sapiens AQP3 (HsAQP3; BC013566), and Bos taurus AQP0
(BtAQP0; NM_173937). Predicted transmembrane domains (TMD1-6) of DrAqp3b are annotated by blue arrows, and external (out) and internal
(in) loops are indicated. The two NPA motifs are shaded in red, whereas the four residues forming the aromatic/arginine (ar/R) constriction in
zebrafish GLPs (Phe, Gly/Ser, Tyr/Ala, and Arg) [48] are pointed by red arrowheads. Potential residues involved in pH sensitivity in AQP0 and -3
orthologs are shaded in green, and mutated residues in DrAqp3b are indicated by black arrowheads.
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DrAqp3b-WT at pH 7.5 and 8.5, respectively, and had
similar Pf at neutral and alkaline pH (Figure 4A). Thus,
substitution of Thr by Ala in the first NPA box of
DrAqp3b increased water permeability and completely
abolished the stimulatory effect of alkaline pH, although
permeability was still inhibited at pH 6. Expression of
the DrAqp3b-A217T and -T85A/A217T mutants in
oocytes decreased the Pf with respect the oocytes
expressing DrAqp3b-WT and did not affect the pH sen-
sitivity of DrAqp3b (Additional file 2).
Since the DrAqp3b-H53A/G54H mutant displayed
higher water permeability at pH 6 than the WT, and the
DrAqp3b-T85A was more permeable and not affected
by alkaline pH, we finally designed and characterized a
triple mutant DrAqp3b-H53A/G54H/T85A (Table 2).
Interestingly, the Pf of oocytes expressing this construct
was insensitive to pH, being 2.2-fold higher than that of
the DrAqp3b-WT oocytes at pH 6 (Figure 4A). The Pf
of these oocytes was, however, 2- and 3.3-times lower,
respectively, than that of DrAqp3b-WT oocytes at pH
7.5 and 8.5.
The mutagenesis experiments rendered two con-
structs, DrAqp3b-T85A and - H53A/G54H/T85A, that
encoded aquaporins with enhanced water permeability
at pH 7.5 and 8.5, or insensitive to pH, respectively. In
order to characterize the expression levels and subcellu-
lar localization of the protein products of these mutants
in X. laevis oocytes, immunocytochemistry and Western
blotting were carried out using an affinity-purified anti-
body against DrAqp3b. Immunofluorescence microscopy
of oocytes expressing DrAqp3b-WT, -T85A or -H53A/
G54H/T85A revealed that in all cases the corresponding
proteins were localized exclusively in the plasma
Table 2 Amino acid sequences of zebrafish wild-type (WT) and mutated Aqp3b
Construct Loop A Loop B Loop C Loop D Loop E
DrAqp3b-WT HILSGGSHGMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
H53A HILSGGSAGMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
G54A HILSGGSHAMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
H53A/G54H HILSGGSAHMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
H53A/G54H/T85A HILSGGSAHMFLTV SGGHINPAVTFSLCLLGREPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
T85A HILSGGSHGMFLTV SGGHINPAVTFSLCLLGREPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
R95A HILSGGSHGMFLTV SGGHINPTVTFSLCLLGAEPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
E96A HILSGGSHGMFLTV SGGHINPTVTFSLCLLGRAPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
R99A HILSGGSHGMFLTV SGGHINPTVTFSLCLLGREPWAKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
H154A HILSGGSHGMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKALTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
G54H/H154A HILSGGSHHMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKALTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
H53A/H154A HILSGGSAGMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKALTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
H53A/G54H/H154A HILSGGSAHMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKALTLL IVDPYNNPIPQGLEA AVNPARDLGPRIFTAIAG
A217T HILSGGSHGMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPTRDLGPRIFTAIAG
T85A/A217T HILSGGSHGMFLTV SGGHINPAVTFSLCLLGREPWRKFP FATYPSKHLTLL IVDPYNNPIPQGLEA AVNPTRDLGPRIFTAIAG
Y182A HILSGGSHGMFLTV SGGHINPTVTFSLCLLGREPWRKFP FATYPSKHLTLL IVDPANNPIPQGLEA AVNPARDLGPRIFTAIAG
Amino acid sequence of the five loops of WT and DrAqp3b mutants. The residues mutated and the substitutions are underlined in bold.
Figure 4 Functional characterization of DrAqp3b mutants. (A) Pf
of control oocytes (water-injected) and oocytes expressing 1 ng
cRNA encoding wild-type DrAqp3b (DrAqp3b-WT) or different
DrAqp3b mutants at different pH. Values are the mean ± SEM of
three experiments (n = 8-10 oocytes per construct). The asterisks
denote significant differences between WT and mutant DrAqp3b at
a given pH (Student’s t test, p < 0.05). (B) Immunofluorescence
microscopy of water-injected oocytes (control), or oocytes
expressing DrAqp3b-WT, -H53A, -H53A/G54H, -T85A and -H53A/
G54H/T85A using an affinity purified anti-DrAqp3b antiserum. The
arrowhead points to the oocyte plasma membrane. (C) Immunoblot
of total membrane protein extracts of control oocytes or oocytes
expressing DrAqp3b-WT treated or not with N-glycosidase F
(PNGase F). The arrows indicate glycosylated and deglycosylated
forms of DrAqp3b-WT. (D) Representative immunoblot of plasma
membrane protein extracts of oocytes expressing increasing
amounts of cRNA (1-8 ng) encoding DrAqp3b-WT, -T85A and
-H53A/G54H/T85A treated with PNGaseF.
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membrane (Figure 4B). Western blot analysis of total
membrane extracts of DrAqp3b-WT injected oocytes
showed a broad and intense immunoreactive band of
approximately 33-40 kDa (Figure 4C). This band corre-
sponded to a glycosylated form of DrAqp3b, since treat-
ment with N-Glycosidase F (PNGase F) rendered a
product of approximately 29 kDa. Immunoblotting of
plasma membrane extracts treated with PNGase F of
oocytes injected with increasing amounts of DrAqp3b-
WT, -T85A or -H53A/G54H/T85A showed that similar
amounts of the protein products were accumulated at
the oocyte plasma membrane (Figure 4D). However, the
DrAqp3b-H53A/G54H/T85A construct resulted in
sligthly more protein at the plasma membrane in com-
parison with the other constructs when 1 ng cRNA was
injected into the oocytes (Figure 4D). Since oocytes
expressing this mutant had lower Pf than the DrAqp3b-
WT and -T85A oocytes at pH 7.5, our observations
confirmed that the differences in Pf between oocytes
expressing DrAqp3b-WT or the mutants were not
derived from differences in translation or in the accu-
mulation of the protein products in the oocyte
membranes.
The permeability of oocytes expressing DrAqp3b-WT,
-T85A or -H53A/G54H/T85A to ethylene glycol was
finally investigated by radioactive uptake assays as
described previously (Figure 5). The data indicated than
the permeability to ethylene glycol of oocytes expressing
the different constructs followed the same pattern as the
Pf. Thus, the DrAqp3b-H53A/G54H/T85A oocytes
showed higher ethylene glycol uptake than the other
oocytes at pH 6, and the uptake did not change at
higher pH. In contrast, at pH 7.5 and 8.5 the DrAqp3b-
T85A oocytes showed the highest ethylene glycol
uptake.
Permeability of DrAqp3b mutants under hypertonic
conditions
The permeability to water and ethylene glycol of oocytes
expressing HsAQP3, DrAqp3b-WT, -T85A or -H53A/
G54H/T85A was subsequently determined in hypertonic
solutions (Figure 6). We first investigated the hydraulic
conductivity (Lp) of oocytes expressing 1 ng of cRNA of
the different constructs immersed in a sucrose solution
(0.9 M). Oocytes from all groups shrank quickly during
approximately the first 2 min of sucrose exposure, and
the shrinkage decreased thereafter, indicating that they
were slowly reaching the equilibration state (Figure 6A).
As expected, aquaporin-expressing oocytes shrank faster
than the controls, although the oocytes expressing
DrAqp3b-T85A shrank more rapidly than the oocytes
expressing the other constructs (Figure 6A). Since we
observed that the shrinkage of oocytes in 0.9 M sucrose
was linear only during the first 2 min, we calculated the
Lp after 2 and 10 min; the Lp at 2 min being more com-
parable to the Pf previously determined under hypotonic
conditions. Accordingly, the Lp values after 2 min of the
DrAqp3b-T85A oocytes were the highest, followed by
the oocytes expressing DrAqp3b-WT, -H53A/G54H/
T85A, HsAQP3 and water-injected oocytes (Table 3).
After 10 min, the Lp of the DrAqp3b-T85A oocytes
remained higher than that of the other groups, whereas
the Lp of the DrAqp3b-WT, -H53A/G54H/T85A and
HsAQP3 oocytes was similar and higher than the con-
trol oocytes (Table 3). Therefore, the results confirmed
that the DrAqp3b-T85A mutant was also the most
permeable to water under hypertonic conditions.
Next, we evaluated the Lp and PEG of oocytes expres-
sing the different constructs under a high concentration
gradient of ethylene glycol (1.3 M) for 10 min. For these
experiments, we used oocytes expressing 1 or 20 ng of
cRNA. The relative volume changes of the oocytes
under these conditions revealed that water-injected
oocytes shrank and did not swell for almost 10 min,
suggesting that ethylene glycol permeated oocytes quite
slowly (Figure 6B and 6C). HsAQP3- and DrAqp3b-
H53A/G54H/T85A-expressing oocytes (1 ng cRNA)
shrank slightly less than controls, and then swelled
slowly, indicating a higher permeability to the cryopro-
tectant (Figure 6B). The DrAqp3b-WT oocytes shrank
less and swelled more than those injected with
DrAqp3b-H53A/G54H/T85A- or HsAQP3, whereas
oocytes expressing DrAqp3b-T85A exhibited few shrink-
age and the fastest re-swelling (Figure 6B). Accordingly,
the Lp values of the DrAqp3b-T85A oocytes in 1.3 M
Figure 5 Ethylene glycol uptake of DrAqp3b-WT and mutants
at different pH. Uptake of radiolabeled ethylene glycol by oocytes
injected with water or with 5 ng of DrAqp3b-WT, -T85A or -H53A/
G54H/T85A cRNA was determined as in Figure 2. Data (mean ±
SEM; n = 8-10 oocytes) with an asterisk are significantly (ANOVA, p
< 0.01) different from the DrAqp3b-WT.
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ethylene glycol were the highest, followed by the
DrAqp3b-WT, -H53A/G54H/T85A, HsAQP3, and con-
trol oocytes (Table 4). This was in agreement with the
data obtained using oocytes exposed to 0.9 M sucrose.
The PEG values also corroborated previous volumetric
and ethylene glycol uptake experiments, since the PEG of
DrAqp3b-T85A oocytes was significantly (p < 0.05)
higher than that of the oocytes expressing the other
constructs or injected with water (Table 4). The reflec-
tion coefficients (s), calculated using the Kedem-Katch-
alsky model (see Methods), were the lowest in
aquaporin-expressing oocytes (data not shown), suggest-
ing that water and solute permeate through the same
pore.
In general, oocytes injected with 20 ng of cRNA of
each construct shrank less and swelled more rapidly
over the 10 min period when compared with oocytes
expressing 1 ng (Figure 6C). For the DrAqp3b-T85A
oocytes, however, no shrinkage was observed but the
Figure 6 Changes in cell volume of oocytes expressing
DrAqp3b-WT, DrAqp3b mutants or HsAQP3 in hypertonic
solutions. (A) Oocytes expressing 1 ng of DrAqp3b-WT, -T85A,
-H53A/G54H/T85A or HsAQP3 were exposed to 0.9 M sucrose in
MBS for 10 min. (B-C) Oocytes expressing 1 (B) or 20 (C) ng of the
same constructs were exposed to 1.3 M ethylene glycol in MBS for
10 min. Data from all panels are means ± SEM of 15-24 oocytes
from 3-4 different batches.
Table 3 Hydraulic conductivity (Lp) of X. laevis oocytes
expressing wild-type (WT) DrAqp3b, DrAqp3b mutants or
HsAQP3 determined after 2 or 10 min in a sucrose
solution
Lp (μm/min/atm)
2 min 10 min
Water 1.40 ± 0.06 a 0.69 ± 0.03 a
DrAqp3b-WT 2.15 ± 0.06 c 0.89 ± 004 b
DrAqp3b-H53A/G54H/T85A 1.94 ± 0.08 b 0.88 ± 004 b
DrAqp3b-T85A 2.57 ± 0.07 d 1.02 ± 0.04 c
HsAQP3 1.93 ± 0.07 b 0.87 ± 0.03 b
Values (mean ± SEM) for water- and aquaporin-injected (1 ng cRNA) oocytes
are calculated from the data in Figure 6A. Data from the same column with
different superscript are statistically significant (ANOVA, p < 0.05).
Table 4 Hydraulic conductivity (Lp) and ethylene glycol
permeability (PEG) of X. laevis oocytes expressing wild-
type (WT) DrAqp3b, two DrAqp3b mutants or HsAQP3, in
hypertonic ethylene glycol solution
Lp (μm/min/
atm)
PEG (x 10
-3 cm/
min)
Water 0.36 ± 0.02 a 0.47 ± 0.03 a
DrAqp3b-WT (1 ng) 2.15 ± 0.14 c 17.59 ± 0.83 d
DrAqp3b-H53A/G54H/T85A (1
ng)
1.55 ± 0.13 b 13.06 ± 0.72 c
DrAqp3b-T85A (1 ng) 2.64 ± 0.15 d 25.49 ± 1.56 e
HsAQP3 (1 ng) 1.31 ± 0.08 b 10.73 ± 0.59 b
DrAqp3b-WT (20 ng) 2.63 ± 0.07 d 40.06 ± 1.22 c
DrAqp3b-H53A/G54H/T85A (20
ng)
2.27 ± 0.07 c 36.58 ± 1.74 c
DrAqp3b-T85A (20 ng) 3.24 ± 0.08 e 53.91 ± 2.55 d
HsAQP3 (20 ng) 1.96 ± 0.08 b 22.24 ± 0.95 b
Values (mean ± SEM) for water- and aquaporin-injected (1 or 20 ng cRNA)
oocytes are calculated from the data in Figure 6B and C. For each cRNA dose,
data with different superscript are statistically significant (ANOVA, p < 0.05).
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oocytes constantly swelled, probably reflecting a very
fast permeation of ethylene glycol into the oocyte. Con-
sistently, 20 ng cRNA-injected oocytes had higher Lp
and PEG values than those injected with 1 ng and, as
observed before, oocytes expressing DrAqp3b-T85A
showed the highest Lp and PEG values (Table 4).
The internal concentration of ethylene glycol in water-
injected oocytes and oocytes expressing the different
constructs after immersion in hypertonic ethylene glycol
was finally assessed. For these experiments, oocytes
were exposed for 10 min to a solution of 1.3 M ethylene
glycol at pH 7.5 containing radiolabeled ethylene glycol.
The results confirmed that the uptake of the cryoprotec-
tant was highly increased under a concentration gradient
(Table 5), since oocytes expressing 1 ng cRNA of the
different constructs showed about 150-fold higher
uptake rate of ethylene glycol than oocytes expressing 5
ng (Figure 5) or 20 ng (Figure 2) cRNA that were
exposed to an isotonic ethylene glycol solution at the
same pH. After 10 min in 1.3 M ethylene glycol, the
internal concentration of the cryoprotectant in oocytes
injected with 1 o 20 ng cRNA of DrAqp3b-T85A was
2.7- and 3.6-times higher, respectively, than that of con-
trol oocytes (Table 5). The ethylene glycol concentration
in oocytes expressing 1 or 20 ng cRNA of DrAqp3b-
WT, -H53A/G54H/T85A, and HsAQP3 was significantly
(p < 0.05) lower than that of DrAqp3b-T85A oocytes,
but still higher than in control oocytes (Table 5).
Discussion
In the present study, we have characterized the perme-
ability of the complete repertoire of zebrafish GLPs to
glycerol, propylene glycol and ethylene glycol in X. lae-
vis oocytes. We found that the two zebrafish Aqp3
isoforms, although pH dependent, are selectively more
permeable to ethylene glycol than to glycerol or propy-
lene glycol under isotonic conditions. Using this prop-
erty, apparently unique among vertebrate aquaporins,
we have developed two mutant constructs based on the
amino acid sequence of DrAqp3b. One of these mutants
was pH insensitive when expressed in oocytes, whereas
the other showed higher water and ethylene glycol per-
meability than the WT in both isotonic and hypertonic
solutions.
It is known that some mammalian aquaporins are
regulated by pH, namely AQP0, -3 and -6 [44,50,56,57].
However, the effect of pH on the permeability of teleost
GLPs has not been reported, except for Aqp3a and -3b
[58,59]. The results from the present study show that
water, glycerol and propylene glycol permeability of
oocytes expressing HsAQP3 at pH 6 was reduced to a
similar extent as in previous studies, whereas permeabil-
ity remained unchanged between pH 7.5 and 8.5
[44,49,60]. Zebrafish Aqp3a, -3b, -7 and -10b were
affected to a variable degree by changes in pH when
expressed in oocytes, although DrAqp3a and -3b were
the most affected aquaporins. Thus, water and cryopro-
tectant permeability of oocytes expressing DrAqp3a or
-3b was completely abolished at pH 6 and was highest
at pH 8.5. Such an effect of pH on aquaporin permeabil-
ity, not observed in HsAQP3, has been previously
reported for the Aqp3a and -3b from killifish and Eur-
opean eel, respectively [58,59], but its physiological sig-
nificance remains to be elucidated. The Pf of oocytes
expressing DrAqp7 or -10b was also diminished at
acidic pH, but only by approximately 50%, a feature that
has not been described for the mammalian orthologs.
Determination of the PGly, PPG and PEG of oocytes
expressing the different zebrafish GLPs under isotonic
conditions indicated that DrAqp3a and -3b were the
only aquaporins more permeable to ethylene glycol than
to glycerol or propylene glycol. HsAQP3 was more
permeable to glycerol than to the other cryoprotectants
under isotonic conditions at pH 7.5 and 8.5, but under
high concentration gradients HsAQP3 might transport
propylene glycol and ethylene glycol as efficiently as gly-
cerol, as it occurs for rat AQP3 expressed in X. laevis
oocytes [31]. Therefore, it is possible that in hypertonic
solutions oocytes expressing DrAqp3a or -3b may be
equally permeable to glycerol, propylene glycol and
ethylene glycol. Nevertheless, our results indicate that
oocytes expressing DrAqp3b and exposed to isotonic or
hypertonic ethylene glycol solutions permeate this cryo-
protectant more efficiently than those expressing
HsAQP3. The DrAqp3b amino sequence shows the resi-
dues forming the ar/R narrowest constriction region
conserved in GLPs, but interestingly, it shows an
unusual first NPA motif, where Ala is substituted by
Table 5 Ethylene glycol content (mol/l) of X. laevis
oocytes expressing different amounts of cRNA encoding
wild-type (WT) DrAqp3b, two DrAqp3b mutants, or
HsAQP3, after immersion in hypertonic ethylene glycol
solution
cRNA injected
1 ng 20 ng
Water 0.11 ± 0.004 a
(6050 ± 220)
DrAqp3b-WT 0.24 ± 0.01 c
(14568 ± 607)
0.34 ± 0.02 d
(21284 ± 1250)
DrAqp3b-H53A/G54H/T85A 0.20 ± 0.01 b
(11980 ± 599)
0.29 ± 0.01 c
(17835 ± 615)
DrAqp3b-T85A 0.33 ± 0.02 d
(20328 ± 1232)
0.43 ± 0.01 e
(27305 ± 635)
HsAQP3 0.20 ± 0.01 b
(11900 ±595)
0.24 ± 0.01 b
(14448 ± 602)
Data are the mean ± SEM (n = 12-18 oocytes) of two different experiments.
Data in parenthesis are in pmol/oocyte/min. Values from the same column
with different superscript are statistically significant (ANOVA, p < 0.05).
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Thr. This amino acid change may be involved in the
increased permeability of DrAqp3b to ethylene glycol
with respect glycerol or propylene glycol, since NPA
motifs form one of the constriction sites of aquaporins
responsible for proton exclusion and size selectivity [61].
However, the observation that changing the NPT motif
of DrAqp3b into NPA increased both water and ethy-
lene glycol permeability does not support this supposi-
tion. The molecular basis of DrAqp3b ethylene glycol
selectivity remains thus unclear and needs to be
investigated.
Ethylene glycol is one of the most suitable cryoprotec-
tants in terms of efficiency/toxicity ratio for the preser-
vation of oocytes and embryos from higher vertebrates
[13-18], as well as from some fish species [3], and there-
fore DrAqp3b may be more effective than mammalian
AQP3 at increasing the internal concentration of ethy-
lene glycol. Water and solute transport through
DrAqp3b is however pH sensitive being maximum at
pH 8.5. To counteract this obstacle, we investigated the
role of sequence motifs in DrAqp3b potentially critical
for pH regulation of water permeability, or that can
enhance ethylene glycol permeability. Mutagenesis
experiments identified one His residue in loop A of
DrAqp3b (His53), spanning the outer region of the pore,
which precise position within the loop regulated the
inhibitory effect of acidic pH on water permeability.
These observations are similar to those reported by
Németh-Cahalan et al. [51] for the fish and bovine
AQP0. In this study, it was suggested that pH can mod-
ulate the orientation of water molecules in the pore by
titrating external His, which would in turn alter the
orientation-dependant electrostatic interactions between
water molecules, thus affecting their effective binding
energies within the pore. In the present work, we also
found that changing the first NPT motif of DrAqp3b
into NPA (DrAqp3b-T85A) shifted the maximal perme-
ability to pH 7.5, allowing for higher water and ethylene
glycol permeability at pH 7.5 and 8.5 with respect the
WT. These findings suggest that Thr85 of DrAqp3b is
involved in the sensitivity of this aquaporin to alkaline
pH. By combining these two observations, a triple
mutant was designed (DrAqp3b-H53A/G54H/T85A)
which was no longer pH sensitive (e.g., exhibited similar
permeability at all pHs), although it was less permeable
at pH 7.5 and 8.5 than the WT.
Increasing cell permeability to water and cryoprotec-
tants, under high concentration gradients, is important for
developing and improving cryopreservation protocols [31].
During slow and fast (vitrification) cooling procedures
employed for cryopreservation, cells have to be exposed to
variable concentrations (around 1.5 M, or >5 M, respec-
tively) of cryoprotectants [14,62]. Our results suggest
that mutated DrAqp3b, with improved cryoprotectant
permeability, may be useful in cryobiology. The Lp and
PEG of oocytes expressing HsAQP3, DrAqp3b-WT,
-T85A- or -H53A/G54H/T85A were measured here in a
solution containing 1.3 M ethylene glycol equivalent to
that used in slow cooling protocols. For both 1- or 20 ng
cRNA-injected oocytes, the Lp and PEG values were the
highest for oocytes expressing DrAqp3b-T85A in agree-
ment with previous observations using isotonic conditions
and a solution of 0.9 M sucrose. The PEG values of oocytes
injected with 20 ng of DrAqp3b-WT or -T85A and
exposed to 1.3 M ethylene glycol were 40.06 × 10-3 and
53.91 × 10-3 cm/min, respectively, whereas those of the
HsAQP3-expressing oocytes were 22.24 × 10-3 cm/min.
Yamaji et al. [31] reported a PEG of 33.5 x10
-3 cm/min of
X. laevis oocytes expressing 40 ng of rat AQP3 and
exposed to the same ethylene glycol concentration. Our
results therefore suggest that DrAqp3b-WT and -T85A
may transport ethylene glycol more efficiently than human
or rat AQP3. However, the Lp (0.02 μm/min/atm) and PEG
(0.11 × 10-3 cm/min) of water-injected oocytes reported
by Yamaji et al. [31] were 18- and 4-times lower, respec-
tively, than those measured in our study (0.36 μm/min/
atm and 0.47 × 10-3 cm/min, respectively) under the same
conditions. The causes of these differences remain
unknown, but they may be related with the observation
that water-injected oocytes shrank faster in our study than
those of Yamaji et al. [31] at a similar ethylene glycol con-
centration. Also, we consistently measured a basal ethy-
lene glycol permeation, under either isotonic or
hypertonic solutions, in water-injected oocytes, in both
swelling and radiolabeled solute uptake assays.
Conclusions
In the present study, we have shown that the pH sensi-
tiveness and ethylene glycol permeability of DrAqp3b
can be altered by single or triple point mutations in its
amino acid sequence. Using this approach, we engi-
neered and functionally characterized two mutant con-
structs, DrAqp3b-T85A- and -H53A/G54H/T85A,
which were either more permeable to water and ethy-
lene glycol than the DrAqp3b-WT or were pH insensi-
tive, respectively. These artificial aquaporins may be
useful for cryopreservation of large cells or multicellular
systems, and investigations in this direction are
underway.
Methods
Aquaporin cDNAs and expression constructs
The GenBank accession numbers of the zebrafish aqua-
porin cDNAs employed in this study were as follows:
Aqp1a (AY626937), Aqp3a (EU341833), Aqp3b
(EU341832), Aqp7 (FJ655385), Aqp9a (FJ655387),
Aqp9b (EU341835), Aqp10a (FJ655388), and Aqp10b
(EU341836). The human AQP3 cDNA (GenBank
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accession number BC013566) was generously provided
by Prof. Peter Deen (Radboud University Nijmegen
Medical Centre, The Netherlands).
Aquaporin constructs for heterologous expression in
X. laevis oocytes were generated by subcloning full-
length aquaporin cDNAs into the pT7Ts expression vec-
tor [63]. Since this vector contains unique BglII, EcoRV
and SpeI cloning sites to allow the gene of interest to be
flanked by the 5’ and 3’ untranslated regions of the X.
laevis b-globin gene, compatible BglII, EcoRV or SpeI
sites were introduced for each aquaporin (depending on
the restriction sites identified in the sequence) by PCR
using high fidelity polymerase (Easy A, Stratagene).
Mutations into the DrAqp3b amino acid sequence were
performed on pT7Ts-DrAqp3b plasmid using the
Quickchange site-directed mutagenesis kit (Stratagene)
and the oligonucleotide primers listed in Additional file
3. Selected clones were sequenced by BigDye Termina-
tor v3.1 cycle sequencing on ABI PRISM 377 DNA ana-
lyzer (Applied Biosystems) to confirm that only the
desired mutations were produced.
Sequence analysis
Vertebrate and teleost aquaporin sequences were
retrieved from the NCBI database [64]. Amino acid
sequence alignments were performed using the Clus-
talW multiple sequence alignment program [65]
employing the full-length amino acid sequence, and
were manually optimized using the Bioedit software
[66].
Functional expression in X. laevis oocytes
The cRNAs for microinjection were synthesized with T7
RNA polymerase (Roche) from XbaI or SalI-linearized
pT7Ts-aquaporin (depending on the restriction sites
identified in the aquaporin sequence). Isolation of stages
V and VI oocytes and microinjection was performed as
previously described [63]. Oocytes were transferred to
MBS (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.82
mM MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, 10
mM HEPES, and 25 μg/ml gentamycin, pH 7.5) and
injected with 50 nl of distilled water (negative control)
or 50 nl of water solution containing 1 to 20 ng of
cRNA. One day after injection, oocytes were manually
defolliculated and subsequently maintained in MBS at
18°C.
Determination of oocyte Pf, PGLY, PPG and PEG at different
pH
Water and solute permeability of oocytes expressing the
different constructs was tested in hypotonic or isotonic
MBS (200 mOsm), respectively, at different pH and at
room temperature (20°C). For the calculation of Pf, two
days after injection the oocytes were transferred to
isotonic MBS (200 mOsm) at pH 6, 7.5 or 8.5 for 15
min, and then transferred to 10-fold diluted MBS (20
mOsmol) at the same experimental pH. Oocyte swelling
was followed by video microscopy using serial images at
2 sec intervals during the first 20 sec period using a
Nikon Color view video camera coupled to a stereomi-
croscope (SMZ1000, Nikon). The Pf values were calcu-
lated taking into account the time-course changes in
relative oocyte volume [d(V/V0)/dt], the partial molar
volume of water (VW = 18 cm
3/mol) and the oocyte sur-
face area (S) using the formula V0[d(V/V0)/dt]/[SVW
(Osmin - Osmout)]. The surface area of the oocyte was
considered to be nine times the apparent area because
membrane folding [67].
Cryoprotectant (glycerol, propylene glycol and ethylene
glycol; Sigma) permeability of water-injected and aqua-
porin-expressing oocytes was determined also volumetri-
cally in isotonic MBS, where NaCl was replaced by 160
mM of the solutes, at different pH. The osmolarity of the
solutions was measured for each experiment with a vapor
pressure osmometer (Vapro® 5520, Wescor), and
adjusted to 200 mOsm with NaCl if necessary. Oocytes
were exposed to different pH as indicated above, and
oocyte swelling was measured by video microscopy, in
this case using serial images at 5 sec intervals during 1
min. In some experiments, the PEG was estimated using
MBS containing 60 or 100 mM ethylene glycol and using
serial images of oocyte swelling as for the Pf. The PGLY,
PPG and PEG were calculated from oocyte swelling using
the formula [d(V/V0)dt]/(S/V0) [68]. The Ps of oocytes
for each of the three cryoprotectants was measured using
the same batch of oocytes.
To ensure that the Pf was not affected by ion dilution
during oocyte volume measurements [69], the NaCl
concentration of MBS was reduced to 78 mM, 50 mM
or 25 mM, and sucrose was added to a concentration of
20 mM, 56 mM and 126 mM, respectively, to obtain
isotonic solutions as determined with the vapor pressure
osmometer. Oocytes were then equilibrated in these
solutions at pH 7.5 for 45 min, and subsequently trans-
ferred to the same solutions at pH 6, 7.5 or 8.5 for 15
min. Oocyte swelling was measured in these solutions
that were made hyposmotic by removing sucrose, and
thus the ion concentrations were constant. The same
control experiments were carried out for the determina-
tion of PEG at different pH. For this, oocytes were equili-
brated in isotonic MBS containing 38 mM NaCl and
100 mM sucrose, which was substituted by 100 mM
ethylene glycol for the swelling measurements.
Determination of the osmotically inactive fraction of X.
laevis oocytes
The water loss of non-injected X. laevis oocytes was
assessed by two types of experiments performed at pH
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7.5 and room temperature. In the first experiment,
oocytes were exposed to a high concentrated sucrose
solution (0.9 M, 1450 mOsm) and the diameter of the
oocytes was recorded after 10 min and 1 h. Oocytes
were also weighed before and after 1 h of exposure to
sucrose. With these data (not shown), we determined
that oocytes did not lose more than 25% of their volume
or weight, which corresponds to the free water content.
For further calculations (see below), the osmotically
inactive volume was taken as 75% of the initial oocyte
volume. From subsequent experiments, where oocytes
were dried in a oven during 24 h, we estimated that the
bound water associated with osmotically inactive volume
of oocytes is 45% of the total water of the oocyte (data
not shown).
Measurement of water and cryoprotectant permeability
of oocytes in hypertonic solutions
The Lp and PEG of water- and aquaporin-injected oocytes
were calculated from their relative volume changes when
exposed to 0.9 M sucrose (1460 mOsm) or 1.3 M ethy-
lene glycol (1600 mOsm) in MBS at pH 7.5 for 10 min at
room temperature. Within this time period, the com-
pounds were not toxic for the oocytes. The change in
oocyte volume were recorded every 10 sec with a video
camera as described above. The data were entered into
the DIFFCHAM software [70] which allows to estimate,
based on the change in concentration of the solutes and
the original volume of the oocyte, values of Lp, PEG and s
for individual oocytes according to the Kedem-Katch-
alsky model (K-K model) [71] of movement of solutes
across cell membranes (see [72] for details). The software
was instructed to model for an extracellular step rise in
sucrose or ethylene glycol concentration, from 0 to 0.9 M
or from 0 to 1.3 M, respectively, with a non-permeating
solute of 200 mOsm corresponding to the MBS solution.
The partial molar volume of ethylene glycol was 54 cm3/
mol, and the gas constant (R) was 82.3 cm3/atm/mol
[31]. The osmotically inactive volume was 75% of the
initial oocyte volume as determined above. Five to seven
oocytes per construct were analyzed individually for each
batch of oocytes. In these experiments, the Pf can be cal-
culated using the formula LpRT/Vw.
Radioactive ethylene glycol uptake assays
The uptake of [1,2-3H]ethylene glycol (American Radi-
olabelled Chemicals Inc.; 20 Ci/mmol) was determined
in oocytes exposed to isotonic and hypertonic solutions
at room temperature. Under isotonic conditions, groups
of 10 oocytes injected with water or aquaporin cRNA
were incubated in 200 μl of isotonic MBS at different
pH containing 5 μM (20 μCi) [1,2-3H]ethylene glycol,
and cold ethylene glycol was added to give 1 mM final
concentration. After 1 min (including zero time for
subtraction of the signal from externally bound solute),
oocytes were washed rapidly in ice-cold MBS three
times, and individual oocytes were dissolved for at least
1 h in 400 μl of 10% SDS for scintillation counting.
To determine the ethylene glycol content of oocytes
exposed to hypertonic 1.3 M ethylene glycol solution in
MBS at pH 7.5, the protocol was the same than above,
except that the exposure to the ethylene glycol solution
was for 10 min, and the washing was carried out in
MBS containing 1.3 M ethylene glycol. An amount of
12 μCi of [1,2-3H]ethylene glycol was added to 120 μl of
1.3 M in MBS containing 6 oocytes (resulting in 73000
cpm/μl). The final concentration (in mol/l) of ethylene
glycol in each oocyte after 10 min exposure was deter-
mined with the formula: [(T10- T0)/73000] × 1.3 μmol/
V; where T10 are the cpm in oocytes after 10 min, T0
are the cpm in oocytes at time 0 (i.e., oocytes exposed
to the solution for one sec), and V is the final oocyte
volume (in μl) after 10 min exposure to 1.3 M ethylene
glycol, which was estimated from the initial oocyte
volume and the changes in volume under 1.3 M ethy-
lene glycol solution previously determined.
Immunofluorescence microscopy and immunoblotting
For immunohistochemistry, oocytes were fixed 4 h in
4% paraformaldehyde in PBS (137 mM NaCl, 2.7 mM
KCl, 100 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) and
then washed, dehydrated and embedded in paraffin as
described [73]. Sections of 7 μm were then rehydrated
and blocked in 5% goat serum, 0.1% BSA in PBST (0.1%
Tween in PBS). Incubation with a DrAqp3b rabbit affi-
nity-purified antiserum (1:250) was performed overnight
at 4°C in 1% goat serum, 0.1% BSA in PBST. The anti-
serum was raised against a synthetic peptide corre-
sponding to the COOH termini of DrAqp3b
(CERLKLSAVSDKDAA) (Agrisera). After washing, sec-
tions were incubated with a secondary anti-rabbit IgG
FITC-coupled antibody (Sigma) for 2 h. Sections were
mounted with fluoromount aqueous anti-fading medium
(Sigma). Immunofluorescence was observed and docu-
mented with a Zeiss imager.z1 microscope.
For Western blotting, total and plasma membrane
protein extracts were isolated from groups of 10 oocytes
as described [74]. Protein samples were denaturated at
95°C in Laemmli sample buffer and the equivalent of 1
oocyte (in 15 μl) for total membrane, or 2 oocytes (in
30 μl) for plasma membrane, were deglycosylated by
incubation with 500 U of PNGase F (New England Bio-
labs Inc.) for 3 h at 37°C. The enzyme was inactivated
by 5 min incubation at 95°C before electrophoresis of
the samples in a 12% SDS-PAGE. Proteins were blotted
on Hybond ECL nitrocellulose membrane (Amersham
Bioscience), and after blocking in 5% nonfat dry milk in
TBST (20 mM Tris, 140 mM NaCl, 0.1% Tween, pH
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7.6), membranes were incubated overnight at 4°C with
anti-DrAqp3b antibody (1:500) diluted in blocking solu-
tion. Bound antibodies were detected with anti rabbit
IgG antibody (1:2000) coupled to horseradish peroxidase
(Rockland Inc.). Reactive protein bands were detected
using Picomax sensitive chemiluminescent HRP sub-
strate (Rockland Inc.).
Statistics
Data are expressed as mean ± SEM. The data on oocyte
water and solute permeability and ethylene glycol con-
tent are an average of 2-4 experiments each performed
on a different batch of oocytes. Data was statistically
analyzed by one-way ANOVA or by the unpaired Stu-
dent’s t test; p values < 0.05 were considered significant.
Additional material
Additional file 1: Effect of pH on the permeability of control and
DrAqp3b-expressing Xenopus laevis oocytes determined in
solutions with diluted or undiluted ion concentrations. Osmotic
water permeability (Pf; A) and ethylene glycol permeability (PEG; B) of
oocytes expressing 2 ng cRNA of DrAqp3b at different pH. In A, oocytes
were preincubated in normal MBS or in isotonic MBS containing 78 mM
NaCl and 20 mM sucrose, and subsequently assayed for Pf using 10
times diluted MBS or a hyposmotic bathing solution made by removing
the sucrose, respectively. The same values of Pf were obtained by using
MBS containing 50 mM or 25 mM NaCl, and 56 mM or 126 mM sucrose,
respectively (data not shown). In B, oocytes were preincubated with
normal MBS or in isotonic MBS containing 38 mM NaCl and 100 mM
sucrose, prior to the swelling assays in isotonic MBS containing 100 mM
ethylene glycol. In both A and B, values are the mean ± SEM of a
representative experiment (n = 6 oocytes).
Additional file 2: Functional characterization of additional DrAqp3b
mutants in Xenopus laevis oocytes. Osmotic water permeability (Pf) of
oocytes expressing wild-type DrAqp3b (DrAqp3b-WT) or different
DrAqp3b mutants at different pH. Values are the mean ± SEM of 2-3
experiments (n = 8-10 oocytes per construct). The asterisks indicate
significant differences between DrAqp3b-WT and mutants at a given pH
(Student’s t test, p < 0.05).
Additional file 3: Forward and reverse primers employed to
introduce mutations into the zebrafish Aqp3b cDNA. The table lists
the oligonucleotide primers employed for the site-directed mutagenesis
of the zebrafish Aqp3b cDNA.
List of abbreviations
AQP: aquaporin; GLP: aquaglyceroporin; Lp: hydraulic conductivity; Pf:
osmotic water permeability; PS: solute permeability; PGly: glycerol
permeability; PPG: propylene glycol permeability; PEG: ethylene glycol
permeability; σ: reflection coefficient; MBS: modified Barth’s medium; PNGase
F: N-Glycosidase F; WT: wild-type.
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